Medtronic
MDT
$0.97 (-1.19%)
1D
1W
3M
1Y
5Y
ALL
Medtronic Public Limited Company is a medical technology and services company. The Company develops, manufactures and markets its medical devices and technologies to hospitals, physicians, clinicians and patients. The Company has four operating and reportable segments that primarily develop, manufacture, distribute, and sell device-based medical therapies and services: the Cardiovascular Portfolio, the Medical Surgical Portfolio, the Neuroscience Portfolio, and the Diabetes Operating Unit. The Cardiac and Vascular Group segment includes Cardiac Rhythm & Heart Failure, Coronary & Structural Heart and Aortic & Peripheral Vascula. Its Minimally Invasive Technologies Group segment includes Surgical Solutions and Patient Monitoring and Recovery. Its Restorative Therapies Group segment includes Spine, Neuromodulation, Surgical Technologies and Neurovascular. Its Diabetes Group segment includes Intensive Insulin Management, Non-Intensive Diabetes Therapies and Diabetes Services & Solutions.
Open
Prior close
Today's high
Today's low
52 Week high
52 Week low
GlobeNewsWire • 3 days ago • MDT
FDA Grants Orchestra BioMed Additional Breakthrough Device Designation for AVIM Therapy
Zacks Investment Research • 5 days ago • MDT
Medtronic (MDT) Falls More Steeply Than Broader Market: What Investors Need to Know
PRNewsWire • 5 days ago • MDT
Medtronic announces CE Mark for Stealth AXiS™ surgical system
The Motley Fool • 6 days ago • MDT
3 Healthcare Stocks That Pay You While You Wait for the Growth
Seeking Alpha • 6 days ago • MDT
Medtronic: Expectations Are Low And That's The Opportunity
Charts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.